Granahan Investment Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,504
| Closed | -$133K | – | 196 |
|
|
2021
Q1 | $133K | Sell |
2,504
-21,088
| -89% | -$1.12M | ﹤0.01% | 190 |
|
|
2020
Q4 | $944K | Sell |
23,592
-4,544
| -16% | -$182K | 0.02% | 185 |
|
|
2020
Q3 | $1.6M | Buy |
28,136
+225
| +0.8% | +$12.8K | 0.05% | 162 |
|
|
2020
Q2 | $2.06M | Sell |
27,911
-854
| -3% | -$63K | 0.07% | 153 |
|
|
2020
Q1 | $1.43M | Buy |
28,765
+5,259
| +22% | +$261K | 0.08% | 152 |
|
|
2019
Q4 | $1.81M | Buy |
23,506
+298
| +1% | +$22.9K | 0.08% | 144 |
|
|
2019
Q3 | $926K | Buy |
23,208
+1,342
| +6% | +$53.5K | 0.05% | 157 |
|
|
2019
Q2 | $735K | Sell |
21,866
-186
| -0.8% | -$6.25K | 0.04% | 169 |
|
|
2019
Q1 | $1.17M | Sell |
22,052
-1,534
| -7% | -$81.3K | 0.06% | 166 |
|
|
2018
Q4 | $1.11M | Sell |
23,586
-421
| -2% | -$19.8K | 0.08% | 162 |
|
|
2018
Q3 | $2.11M | Buy |
24,007
+1,207
| +5% | +$106K | 0.11% | 152 |
|
|
2018
Q2 | $2.37M | Buy |
+22,800
| New | +$2.37M | 0.14% | 153 |
|